Go to navigation Go to content
Toll-Free: 800-752-0042
Phone: 757-460-7776
Shapiro & Appleton

Deadly Side Effects Associated with HIV Drug Intelence

Comments (0)

The HIV drug Intelence, produced by Johnson & Johnson, has potentially deadly side effects including severe skin reactions and liver damage, according to the Associated Press.

The skin reactions include cases of Stevens-Johnson syndrome, a life-threatening skin disorder which starts with fever, sore throat and fatigue. It's extremely debilitating and causes the skin to burn from the inside out producing blisters and causing skin to fall from the body, according to Medscape.com. When the skin lesions affect over 30 percent of your body, the condition is called Toxic Epidermal Necrolysis.

Intelence is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and part of the etravirine family of medications. Its primary function is to block the enzyme HIV needs to multiply. NNRTI medications commonly produce side effects including skin rash, but not the severe Stevens-Johnson syndrome, according to WebMD.

As an injury lawyer who's represented clients hurt by medications, these types of side effects are extremely distressing and the FDA needs to examine Intelence, and HIV medications like it, to ensure they don't produce other life-threatening side effects.

About the Editors: Shapiro & Appleton& Duffan personal injury law firm is based in Virginia (VA), near the NE North Carolina (NC) border and handles car,truck,railroad, and medical negligence cases and more. Our lawyers proudly edit the Virginia Beach Injuryboard, Norfolk Injuryboard, and Northeast North Carolina Injuryboard as a pro bono public information service. Lawyers licensed in: VA, NC, SC, WV, DC, KY.

 

PA

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Message:*

Notify me of follow-up comments via email.

Avvo The Best lawyers in America Super lawyers Best Law Firms US News Verdicts and Settlements AV LexisNexis

Live Chat